Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients

Auteurs

L. Boussemart, E. Routier, C. Mateus, K. Opletalova, G. Sebille, N. Kamsu-Kom, M. Thomas, S. Vagner, M. Favre, G. Tomasic, J. Wechsler, L. Lacroix, C. Robert